We are live on ! Find out more
BPTH

Bio-Path Holdings Inc
BPTH

Delisted

BPTH was delisted on the 18th of February, 2025.

Back to rankings

15 hedge funds and large institutions have $1.49M invested in Bio-Path Holdings Inc in 2019 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 4

12% less funds holding

Funds holding: 17 → 15 (-2)

25% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 4

59% less capital invested

Capital invested by funds: $3.66M → $1.49M (-$2.16M)

Holders
15
Holders Change
-2
Holders Change %
-11.76%
% of All Funds
0.33%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
4
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$109K
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$75.7K
3
Bank of Montreal
Bank of Montreal
Ontario, Canada
+$39.7K
4
Bank of America
Bank of America
North Carolina
+$1.74K
5
GRP
Global Retirement Partners
California
+$745

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$919K
2
Morgan Stanley
Morgan Stanley
New York
-$223K
3
Millennium Management
Millennium Management
New York
-$134K
4
SWP
Stratos Wealth Partners
Ohio
-$134K
5
UBS Group
UBS Group
Switzerland
-$19.6K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$444K -$919K -3,704 -61%
BlackRock
2
BlackRock
New York
$442K -$4.72K -19 -0.8%
Vanguard Group
3
Vanguard Group
Pennsylvania
$348K +$109K +438 +31%
Geode Capital Management
4
Geode Capital Management
Massachusetts
$189K +$75.7K +305 +44%
Bank of Montreal
5
Bank of Montreal
Ontario, Canada
$30K +$39.7K +160 +16,000%
Morgan Stanley
6
Morgan Stanley
New York
$19K -$223K -897 -90%
LTFS
7
Ladenburg Thalmann Financial Services
Florida
$10K – – –
Wells Fargo
8
Wells Fargo
California
$5K – – –
UBS Group
9
UBS Group
Switzerland
$2K -$19.6K -79 -88%
CAPTRUST Financial Advisors
10
CAPTRUST Financial Advisors
North Carolina
$2K – – –
GRP
11
Global Retirement Partners
California
$1K +$745 +3 New
Royal Bank of Canada
12
Royal Bank of Canada
Ontario, Canada
$1K +$745 +3 New
Bank of America
13
Bank of America
North Carolina
$1K +$1.74K +7 +700%
BNP Paribas Financial Markets
14
BNP Paribas Financial Markets
France
$10 – – –
Millennium Management
15
Millennium Management
New York
– -$134K -500 Closed
SWP
16
Stratos Wealth Partners
Ohio
– -$134K -500 Closed
SL
17
Salomon & Ludwin
Virginia
– -$7K -26 Closed
AG
18
Advisor Group
Arizona
– -$4K -15 Closed
SFS
19
Sowell Financial Services
Arkansas
– +$248 +1 New

BPTH Hedge Fund Activity: Q3 2019 in Review

15 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q3 2019, worth a combined $1.49M — down 59% from $3.66M a quarter earlier.

Sellers outnumbered buyers: 4 funds closed out of BPTH and 3 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 4 added.

The largest buyer was Vanguard Group, adding an estimated $109K. The largest seller was Renaissance Technologies, cutting an estimated $919K.

  • 15 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q3 2019, down from 17 in Q2 2019.
  • Funds reported $1.49M of Bio-Path Holdings Inc stock for Q3 2019, down 59% quarter-over-quarter.
  • 3 funds opened new Bio-Path Holdings Inc positions in Q3 2019 and 4 closed out, a net change of -1 holder.
  • The largest Bio-Path Holdings Inc buyer in Q3 2019 was Vanguard Group, an estimated $109K added.
  • The largest Bio-Path Holdings Inc seller in Q3 2019 was Renaissance Technologies, an estimated $919K sold.

Based on aggregated 13F filings for Q3 2019.